Optimizing Fludarabine Exposure Using Pharmacokinetic Modeling in Children Receiving Tisagenlecleucel: A Step Toward Personalized Lymphodepletion

Key Points

• Fludarabine exposure optimization enhances the effectiveness of tisagenlecleucel therapy.
• Children receiving tisagenlecleucel showed improved outcomes when fludarabine was personalized for individual metabolism.
• Pharmacokinetic modeling guided the dosing adjustments for fludarabine administration in pediatric patients.
• These findings may prompt more personalized treatment protocols in lymphodepletion therapies.